Inhaled corticosteroids with combination inhaled long-acting beta2 -agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

Inhaled corticosteroids with combination inhaled long-acting beta2 -agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease

Published:2016-11-10 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Tan Daniel J¹,White Clinton J²,Walters Julia AE²,Walters E Haydn³

Affiliation:

1. Allergy and Lung Health Unit, Melbourne School of Population and Global Health; University of Melbourne; Melbourne Australia

2. School of Medicine; University of Tasmania; Hobart Australia

3. NHMRC Centre of Research Excellence for Chronic Respiratory Disease; School of Medicine, University of Tasmania; Hobart Australia

Publisher

Wiley

Subject

Pharmacology (medical)

Reference40 articles.

1. Short-term effects of inhalative tiotropium/formoterol/budesonide versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomised trial;Bölükbas;European Journal of Cardio-Thoracic Surgery,2011

2. Hara K Kurashima K Tokunaga D Ueno M Aoyagi K Isobe Z Single blind comparison of tiotropium and salmeterol plus fluticasone propionate of treatment in patients with chronic obstructive pulmonary disease (COPD) [Abstract] American Thoracic Society International Conference; 2007 May 18-23; San Francisco San Francisco, California, USA 2007 Poster #A1

3. A comparative study on inhaled corticosteroids versus placebo in management of chronic obstructive pulmonary disease;James;Lung India,2013

4. Exacerbation risk is not worse when ICS are withdrawn in a stepwise manner in severe to very severe COPD patients receiving LAMA+LABA: The WISDOM study;Magnussen;Chest,2014

5. The impact of stepwise withdrawal of ICS on FEV1, mMRC, and SQRQ in severe to very severe COPD patients treated with LAMA+LABA: The WISDOM study;Magnussen;Chest,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease;Cochrane Database of Systematic Reviews;2023-12-06

2. For people with stable chronic obstructive pulmonary disease (COPD), what is the effect of inhaled corticosteroids (ICS) as an adjunct to combined beta-agonist (LABA)/muscarinic antagonist (LAMA) inhalers?;Cochrane Clinical Answers;2020-06-10

3. Drugs that Act on the Respiratory Tract;Side Effects of Drugs Annual;2017